Expansion in Neurology UCB has recently sold assets and launched programs in the neurology field, indicating a focus on this therapeutic area. Targeting healthcare providers and institutions specialized in neurology for partnership opportunities could be advantageous.

Digital Health Collaboration Partnering with remote monitoring specialists like Inhealthcare and expert clinicians for digital health platforms presents an opportunity to introduce UCB's products and solutions to a wider audience. Exploring collaborations in the digital healthcare space could lead to increased market penetration.

Clinical Toolkit Development With ongoing development of the Clinical Toolkit for Preventing Epilepsy Deaths, UCB is actively involved in advancing clinical solutions. Engaging with organizations involved in epilepsy management and healthcare professionals in this field could open up avenues for promoting UCB's pharmaceutical offerings.

Strategic Partnerships in Rheumatology The FASTRAX program by UCB focuses on transforming rheumatology care, presenting an opportunity for strategic partnerships with rheumatology clinics, healthcare facilities, and patient advocacy groups. Collaborating with such entities could help expand UCB's market presence in the rheumatology sector.

Lupus Therapeutics Collaboration The partnership with Lupus Therapeutics offers a window for UCB to explore collaborations in the field of lupus treatment and research. Engaging with research institutions, patient organizations, and healthcare professionals specializing in lupus can create avenues for introducing UCB's products in this niche market.